These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17917441)

  • 1. Comparative bioavailability of norfloxacin tablets based on blood and urine data.
    Nada AH; Sharaf MA; El Gholmy ZA; Khalafallah NM
    Med Princ Pract; 2007; 16(6):426-31. PubMed ID: 17917441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability of two brands of norfloxacin.
    Seth SD; Beotra A; Seth S
    J Assoc Physicians India; 1995 May; 43(5):324-6. PubMed ID: 9081960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
    Khan MK; Khan MF
    Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence evaluation of norfloxacin tablets based on in vitro - in vivo correlation.
    Khiljee S; Ahmad M; Murtaza G; Madni A; Akhtar N; Akhtar M
    Pak J Pharm Sci; 2011 Oct; 24(4):421-6. PubMed ID: 21959800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence evaluation of norfloxacin 400 mg tablets (Uroxin and Noroxin) in healthy human volunteers.
    Al-Rashood K; Al-Khamis K; El-Sayed Y; Al-Bella S; Al-Yamani M; Alam S; Dham R
    Biopharm Drug Dispos; 2000 Jul; 21(5):175-9. PubMed ID: 11180196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence of a generic metformin tablet preparation.
    Yuen KH; Wong JW; Billa N; Julianto T; Toh WT
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):319-22. PubMed ID: 10442505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations.
    Pillai G; Ellard GA; Smith PJ; Fourie PB
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):691-5. PubMed ID: 11495257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute bioavailability of quinine formulations in Nigeria.
    Babalola CP; Bolaji OO; Ogunbona FA; Ezeomah E
    Afr J Med Med Sci; 2004 Sep; 33(3):185-9. PubMed ID: 15819461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
    Goren MP; Houle JM; Bush DA; Li JT; Newman CE; Brade WP
    Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC.
    Khan MK; Khan MF
    Pak J Pharm Sci; 2008 Jul; 21(3):299-306. PubMed ID: 18614429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioavailability study of two ketoconazole tablet preparations.
    Yuen KH; Wong JW; Billa N; Choy WP; Julianto T
    Med J Malaysia; 1999 Dec; 54(4):482-6. PubMed ID: 11072466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative crossover, randomized, open-label bioequivalence study on the bioequivalence of two formulations of thioctic acid in healthy volunteers.
    Mignini F; Streccioni V; Tomassoni D; Traini E; Amenta F
    Clin Exp Hypertens; 2007 Nov; 29(8):575-86. PubMed ID: 18058482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pooling of clodronate urinary excretion data: a new pharmacokinetic method to study drugs with highly variable gastrointestinal absorption.
    Castrén-Kortekangas P; Löyttyniemi E; Liukko-Sipi S; Juhakoski A; Smal J; Laitinen K
    J Bone Miner Res; 1997 Jan; 12(1):66-71. PubMed ID: 9240727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
    Lissy M; Stiff DD; Kowalski MM; Moore KA
    Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.